Consonance Capital Management LP Uro Gen Pharma Ltd. Transaction History

Consonance Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$23.83 - $36.44 $34.2 Million - $52.2 Million	-1,433,774 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$32.75 - $40.35 $10.7 Million - $13.1 Million	-325,550 Reduced 18.5%	1,433,774 $51.5 Million
Q1 2019 May 15, 2019	BUY	$35.47 - $54.55 $8.65 Million - $13.3 Million	243,902 Added 16.09%	1,759,324 $65 Million
Q3 2018 Nov 14, 2018	BUY	$41.65 - $51.7 $1.16 Million - $1.44 Million	27,931 Added 1.88%	1,515,422 $71.6 Million
Q2 2018 Aug 14, 2018	BUY	$48.35 - $65.33 $16.5 Million - $22.3 Million	341,294 Added 29.78%	1,487,491 $74 Million
Q1 2018 May 15, 2018	BUY	$38.64 - $57.54 $8.88 Million - $13.2 Million	229,747 Added 25.07%	1,146,197 $57 Million
Q4 2017 Feb 14, 2018	BUY	$27.28 - $43.26 $25 Million - $39.6 Million	916,450	916,450 $34.1 Million

120

39.3M

158K

161K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $282M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.